SCHEMBL22103784

SCHEMBL22103784

CC(C)(C)c1csc(NC(=O)Nc2ccc(Cl)cc2)n1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.76
SMN1; SMN2 Q16637 5/20 0.76
POLB P06746 4/20 0.76
NPC1 O15118 4/20 0.76
MEN1 O00255 4/20 0.76
KMT2A Q03164 4/20 0.76
ALDH1A1 P00352 2/20 0.76
MAPK1 P28482 2/20 0.76
FFAR2 O15552 1/20 0.61
KDM4E B2RXH2 2/20 0.60
TDP1 Q9NUW8 1/20 0.60
LMNA P02545 2/20 0.56
HTT P42858 2/20 0.56
NPSR1 Q6W5P4 1/20 0.56
HSD17B10 Q99714 1/20 0.56
MAPT P10636 5/20 0.56
ATM Q13315 1/20 0.56
CYP1A2 P05177 2/20 0.55
CYP2C19 P33261 2/20 0.55
RECQL P46063 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14014120 0.89 RAB9A (0.80) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL10078887 0.86 MEN1 (1.00) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL20788543 0.85 NPC1 (0.77) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL20791859 0.82 NPC1 (0.76) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL13234810 0.82 NPC1 (0.69) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL17988256 0.82 RAB9A (1.00) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL22125497 0.81 SMARCA2 (0.72) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL78768 0.80 FFAR2 (0.60) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL21708002 0.80 CCR4 (0.71) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL5459405 0.78 RAB9A (0.62) RAB9ASMN1; SMN2POLBNPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020123675-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER DUKE UNIVERSITY (US) 2020-06-18 WO disclosed